Marc Grasso
About Marc Grasso
Title: Chief Financial Officer
Marc Grasso currently holds the position of Chief Financial Officer. His financial acumen and leadership skills have been honed through a series of high-level roles in the financial sector, particularly within the biotechnology and life sciences industries.
Education and Expertise
Marc Grasso received his M.D. from the Johns Hopkins University School of Medicine, where he also conducted research in molecular oncology. He obtained his A.B. in molecular biology with honors from Princeton University. This solid educational foundation in both medicine and molecular biology underscores his expertise in the life sciences field.
Previous Roles at Kura Oncology
Marc Grasso served as Chief Financial Officer and Chief Business Officer at Kura Oncology, Inc. During his tenure, he played a pivotal role in the financial and strategic operations of the company, contributing to its growth and success in the oncology sector.
Investment Banking Experience
Marc Grasso held a series of leadership positions in investment banking. As Managing Director of Stifel, he built and managed the west coast life sciences and biotechnology investment banking business. He was also Managing Director of Investment Banking in the Global Healthcare Group at UBS, focusing on biotechnology. At Leerink Swann, he was instrumental in expanding their west coast franchise. Earlier in his career, he worked with Morgan Stanley, Credit Suisse First Boston, and Deutsche Banc Alex. Brown, gaining extensive experience in the global healthcare sector.
Research in Molecular Oncology
Marc Grasso performed research in molecular oncology at Johns Hopkins University School of Medicine. This research experience has provided him with a deep understanding of the scientific foundations underlying the biotechnology and life sciences industries, enhancing his ability to evaluate and support cutting-edge scientific ventures.